PECAM1 and type 2 diabetes mellitus: Compared with non-DM metabolic syndrome, the plasma percentage of combined CD62E+ and CD31+ EMPs was significantly downregulated in T2DM, suggesting that a majority of plasma EMPs are released from apoptotic endothelial cells rather than activated endothelial cells in T2DM patients.